These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24269123)

  • 1. Evaluation of benzoic acid derivatives as sirtuin inhibitors.
    Chen YP; Catbagan CC; Bowler JT; Gokey T; Goodwin ND; Guliaev AB; Wu W; Amagata T
    Bioorg Med Chem Lett; 2014 Jan; 24(1):349-52. PubMed ID: 24269123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, in-vitro evaluation and molecular docking studies of novel indole derivatives as inhibitors of SIRT1 and SIRT2.
    Manjula R; Gokhale N; Unni S; Deshmukh P; Reddyrajula R; Srinivas Bharath MM; Dalimba U; Padmanabhan B
    Bioorg Chem; 2019 Nov; 92():103281. PubMed ID: 31561106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of sirtinol analogues as class III histone/protein deacetylase (Sirtuin) inhibitors.
    Mai A; Massa S; Lavu S; Pezzi R; Simeoni S; Ragno R; Mariotti FR; Chiani F; Camilloni G; Sinclair DA
    J Med Chem; 2005 Dec; 48(24):7789-95. PubMed ID: 16302818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creation of an HDAC-based yeast screening method for evaluation of marine-derived actinomycetes: discovery of streptosetin A.
    Amagata T; Xiao J; Chen YP; Holsopple N; Oliver AG; Gokey T; Guliaev AB; Minoura K
    J Nat Prod; 2012 Dec; 75(12):2193-9. PubMed ID: 23167691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening.
    Grozinger CM; Chao ED; Blackwell HE; Moazed D; Schreiber SL
    J Biol Chem; 2001 Oct; 276(42):38837-43. PubMed ID: 11483616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hit-to-lead optimization on aryloxybenzamide derivative virtual screening hit against SIRT.
    Yagci S; Gozelle M; Kaya SG; Ozkan Y; Aksel AB; Bakar-Ates F; Dundar Y; Eren G
    Bioorg Med Chem; 2021 Jan; 30():115961. PubMed ID: 33360574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trichostatin analogues JBIR-109, JBIR-110, and JBIR-111 from the marine sponge-derived Streptomyces sp. RM72.
    Hosoya T; Hirokawa T; Takagi M; Shin-ya K
    J Nat Prod; 2012 Feb; 75(2):285-9. PubMed ID: 22276693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional complementation of sir2Δ yeast mutation by the human orthologous gene SIRT1.
    Gaglio D; D'Alfonso A; Camilloni G
    PLoS One; 2013; 8(12):e83114. PubMed ID: 24349441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of bicyclic pyrazoles as class III histone deacetylase SIRT1 and SIRT2 inhibitors.
    Therrien E; Larouche G; Nguyen N; Rahil J; Lemieux AM; Li Z; Fournel M; Yan TP; Landry AJ; Lefebvre S; Wang JJ; MacBeth K; Heise C; Nguyen A; Besterman JM; Déziel R; Wahhab A
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2514-8. PubMed ID: 25971769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a sirtuin 3 inhibitor that displays selectivity over sirtuin 1 and 2.
    Galli U; Mesenzani O; Coppo C; Sorba G; Canonico PL; Tron GC; Genazzani AA
    Eur J Med Chem; 2012 Sep; 55():58-66. PubMed ID: 22835719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a small molecule inhibitor of Sir2p.
    Bedalov A; Gatbonton T; Irvine WP; Gottschling DE; Simon JA
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15113-8. PubMed ID: 11752457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual screening approach of sirtuin inhibitors results in two new scaffolds.
    Kokkonen P; Kokkola T; Suuronen T; Poso A; Jarho E; Lahtela-Kakkonen M
    Eur J Pharm Sci; 2015 Aug; 76():27-32. PubMed ID: 25936698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton.
    Sakai T; Matsumoto Y; Ishikawa M; Sugita K; Hashimoto Y; Wakai N; Kitao A; Morishita E; Toyoshima C; Hayashi T; Akiyama T
    Bioorg Med Chem; 2015 Jan; 23(2):328-39. PubMed ID: 25515955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of (5-Phenylfuran-2-yl)methanamine Derivatives as New Human Sirtuin 2 Inhibitors.
    Wang L; Li C; Chen W; Song C; Zhang X; Yang F; Wang C; Zhang Y; Qian S; Wang Z; Yang L
    Molecules; 2019 Jul; 24(15):. PubMed ID: 31357491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The flavoring agent dihydrocoumarin reverses epigenetic silencing and inhibits sirtuin deacetylases.
    Olaharski AJ; Rine J; Marshall BL; Babiarz J; Zhang L; Verdin E; Smith MT
    PLoS Genet; 2005 Dec; 1(6):e77. PubMed ID: 16362078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in inhibitors of sirtuin1/2: an update and perspective.
    Zhou Z; Ma T; Zhu Q; Xu Y; Zha X
    Future Med Chem; 2018 Apr; 10(8):907-934. PubMed ID: 29642711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of certain benzothieno[3,2-d]pyrimidine derivatives as a selective SIRT2 inhibitors.
    Khalil NA; Ahmed EM; Zaher AF; El-Zoghbi MS; Sobh EA
    Eur J Med Chem; 2020 Feb; 187():111926. PubMed ID: 31812033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Fungal Metabolite Eurochevalierine, a Sequiterpene Alkaloid, Displays Anti-Cancer Properties through Selective Sirtuin 1/2 Inhibition.
    Schnekenburger M; Mathieu V; Lefranc F; Jang JY; Masi M; Kijjoa A; Evidente A; Kim HJ; Kiss R; Dicato M; Han BW; Diederich M
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29401749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carprofen analogues as sirtuin inhibitors: enzyme and cellular studies.
    Mellini P; Carafa V; Di Rienzo B; Rotili D; De Vita D; Cirilli R; Gallinella B; Provvisiero DP; Di Maro S; Novellino E; Altucci L; Mai A
    ChemMedChem; 2012 Nov; 7(11):1905-8. PubMed ID: 24155041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells.
    Yang LL; Wang HL; Zhong L; Yuan C; Liu SY; Yu ZJ; Liu S; Yan YH; Wu C; Wang Y; Wang Z; Yu Y; Chen Q; Li GB
    Eur J Med Chem; 2018 Jul; 155():806-823. PubMed ID: 29957526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.